$2M NIH Grant to Address Pseudomonas-Linked Lung Infections
Funds from NIH will advance ALX1 as a potential treatment in cystic fibrosis and other chronic lung diseases.
Funds from NIH will advance ALX1 as a potential treatment in cystic fibrosis and other chronic lung diseases.
Funds from NIH will advance ALX1 as a potential treatment in cystic fibrosis and other chronic lung diseases.
Read MoreThe device is intended to promote and improve bronchial drainage by using high-frequency oscillatory vibrations and intermittent negative pressure.
Read MoreData shows that metered cryospray therapy with the investigational RejuvenAir System leads to airway remodeling and improved symptoms in chronic bronchitis patients.
Read MoreResearchers have developed enzyme-powered nanobots capable of navigating through mucus barriers—which typically keep out locally administered drug treatments.
Read MoreA closer look at suction and secretion clearance devices from ABM Respiratory, Neotech, Precision Medical, Seoil Pacific, and Tactile Medical.
Read MoreElectromed Inc has entered into a distribution agreement with Marathon Medical Corp, a medical supply distribution company and service-disabled veteran-owned small business (SDVOSB).
Read MoreScientists have engineered a living material resembling human phlegm, which will help them to better understand how a certain kind of infection develops on the lungs of patients with cystic fibrosis.
Read MoreSynthetic molecules allowed previously-blocked chloride ions to create 50% more mucus-clearing liquid in cystic fibrosis cells.
Read MoreMercury Medical will be the exclusive US distributor for ABM Respiratory Care’s airway clearance therapy devices, the BiWaze Cough and BiWaze Clear.
Read MoreA new study finds that idrevloride in hypertonic saline is safe and associated with a significant improvement in lung function in individuals with primary ciliary dyskinesia when compared to hypertonic saline alone.
Read MoreA closer look at suction and secretion clearance devices from Neotech, Philips/Respirtech, Seoil Pacific, and Tactile Medical.
Read MoreCombination therapy involving three drugs—elexacaftor, tezacaftor, and ivacaftor—can achieve positive, lasting effects in patients with cystic fibrosis, according to new research evaluating the therapy over 12 months.
Read MoreBrigham and Women’s Hospital researchers conducted a study linking mucus plugs to higher mortality.
Read MoreBronchiectasis is linked to several underlying causative agents and involves permanent airway damage, dilated bronchi, retained secretions, chronic infection, and persistent inflammation. But respiratory therapists have several airway clearance therapy options to treat the disease.
Read MoreAutopsied lungs of COVID-19 victims had “widespread” airway occlusion due to mucus accumulation, specifically MUC5B mucins.
Read MoreMUC5AC, an airway protein, plays an important (and overlooked) role in the body’s mucociliary clearance system, according to research published in Science Advances.
Read MoreVaping with nicotine impairs ciliary beat frequency, dehydrates airway fluid and makes mucus more viscous or sticky, new research has found.
Read MoreSuction? PEP? Percussion? Oscillation? Cough assist? With an array of airway clearance therapy options available for respiratory therapists, how do RTs choose the right method for the job?
Read MoreA specific mucin in the airways called MUC5AC could become a target of better therapeutics to untangle the super thick and sticky mucus that plagues COPD and cystic fibrosis patients.
Read MoreNew research looks at the disfunction of mucus response in respiratory epithelial cells in people with asthma.
Read MoreStaphylococcus aureus can cause lung infections and is often present in the mucus and sputum of children with cystic fibrosis.
Read MoreUniversity of Pittsburgh researchers hope that new insights into the role of mucus in cystic fibrosis (CF) can lead to better CF treatments.
Read MoreResearchers at the University of Virginia School of Engineering and other across the country are working on a computer model to understand which genes cause cystic fibrosis and other diseases.
Read MorePatients with respiratory muscle weakness as a result of neuromuscular-neurodegenerative diseases like amyotrophic lateral sclerosis (ALS) or Duchenne Muscular Dystrophy (DMD) or spinal cord injuries may require secretion clearance therapy to clear mucus and prevent lung infections.
Read More